Read Time:25 Seconds
The biotech company will begin its late-stage trial testing a potential vaccine to prevent Covid-19 on July 27. 30,000 people will be enrolled in the trial across 87 locations. The first trial began in March, and the results were disclosed in May, showing the production of neutralizing antibodies against Covid-19. Several other companies are working on a potential vaccine for the global pandemic, for example, just a few days ago, Pfizer announced positive results in their trials.
Source: CNBC.
156100cookie-checkModerna’s Coronavirus Vaccine Will Begin Trial on July 27